Earnings call transcript: Evoke Group’s mixed results amid UK duty changes in H2 2025

Evoke Group delivered mixed but generally resilient FY2025 results, with revenue up 2% to GBP 1.8 billion and adjusted EBITDA up 14% to GBP 356 million, lifting margin 220bps to 20%. Leverage improved from 5.7x to 5.2x and underlying free cash flow was GBP 188 million, but UK duty changes remain a major headwind and management withheld forward guidance amid an ongoing strategic review. International growth was strong, especially Italy and Denmark, while retail and UK online faced pressure from tax changes and market shifts.

Analysis

META is the clean loser here not because ad demand is weak, but because capex is becoming the market’s preferred proxy for future dilution of free cash flow. When a platform is already priced for operating leverage, any incremental AI spend that does not visibly convert to revenue within the next 2-3 quarters tends to compress the multiple faster than the EPS estimate itself. The second-order effect is that capital-light internet peers and ad-tech beneficiaries can outperform as investors rotate toward names with clearer near-term cash conversion rather than frontier AI spending.

EVOK is a different story: the equity setup is more about regulatory shock absorption and optionality than headline fundamentals. The key incremental takeaway is that margin gains are being used to fund a smaller, more profitable footprint, which makes the business less cyclical than the market still assumes. The underappreciated upside is that market consolidation after duty/tax changes can improve pricing discipline for tier-one operators, while weaker long-tail competitors and black-market leakage disproportionately pressure fringe players rather than the incumbent with scale and brand.

The contrarian angle is that the EVOK move may be underdone if the market is treating this as a pure tax-drag story. If mitigation holds and international mix keeps shifting toward higher-margin geographies, the earnings base can re-rate even with muted top-line growth. On META, the risk is that this is less a one-day de-rating event and more the start of a longer-duration debate about AI intensity versus monetization, with any miss on capex efficiency likely to bleed into sentiment for months rather than days.

Key Decisions for Investors

• Short META on a 1-4 week horizon into the post-earnings hangover; use a defined-risk put spread if implied vol stays elevated. Thesis: multiple compression from capex intensity can outweigh near-term operating strength if management does not give a credible ROI timeline.
• Pair trade: long EVOK / short a basket of smaller UK-facing gaming or retail-exposed names over 1-3 months. Thesis: EVOK’s scale and brand should capture share as regulation cleans up weaker competitors; downside is a faster-than-expected deterioration in consumer spend.
• Buy EVOK on pullbacks only, targeting a 3-6 month hold. Risk/reward favors a gradual re-rating if mitigation and deleveraging continue; stop if retail closures fail to translate into margin/FCF improvement by the next update.
• Long META only via call spreads after the market digests capex concerns, not outright stock. If management demonstrates monetization from AI within 1-2 quarters, the downside from current levels should be capped and upside comes from sentiment repair.
• Consider a relative-value long XLK / short internet platform basket for 2-6 weeks if the market starts rewarding software/hardware names with clearer AI monetization and punishing capex-heavy platforms.